Now Available: Spotlight on DELFI Diagnostics CEO Susan Tousi. Click here to read.
Partnership combines Integrated Biosciences’ pioneering research in AI/ML-enabled small molecule drug discovery and bulk and single cell sequencing offered through Illumina Ventures Labs
Tagomics, developers of a cutting-edge platform for comprehensive disease insight and diagnosis, today announces a £6.7m funding round.
Stilla Technologies, the start-up leading innovations in digital PCR, announced it has closed a $26.5 million Series C financing.
Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today it has extended its Series A financing round with an additional close of $25.5 million, bringing the total Series A amount raised to $59.5 million.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
